Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 1
1968 2
1970 1
1978 2
1981 3
1982 2
1983 5
1984 4
1985 9
1986 1
1987 1
1988 4
1989 7
1990 1
1991 6
1992 3
1993 1
1997 1
1998 2
1999 4
2000 8
2001 3
2002 6
2003 5
2004 5
2005 9
2006 9
2007 14
2008 15
2009 26
2010 24
2011 21
2012 10
2013 8
2014 11
2015 7
2016 17
2017 12
2018 19
2019 12
2020 31
2021 47
2022 39
2023 46
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N. Berghmans T, et al. Among authors: moretti l. Lung Cancer. 2018 Dec;126:25-31. doi: 10.1016/j.lungcan.2018.10.018. Epub 2018 Oct 18. Lung Cancer. 2018. PMID: 30527189 Review.
Lung Cancer in Belgium.
Ocak S, Tournoy K, Berghmans T, Demedts I, Durieux R, Janssens A, Moretti L, Nackaerts K, Pieters T, Surmont V, Van Eycken L, Vrijens F, Weynand B, van Meerbeeck JP. Ocak S, et al. Among authors: moretti l. J Thorac Oncol. 2021 Oct;16(10):1610-1621. doi: 10.1016/j.jtho.2021.07.022. J Thorac Oncol. 2021. PMID: 34561034 Free article. No abstract available.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Turner NC, Kingston B, Kilburn LS, Kernaghan S, Wardley AM, Macpherson IR, Baird RD, Roylance R, Stephens P, Oikonomidou O, Braybrooke JP, Tuthill M, Abraham J, Winter MC, Bye H, Hubank M, Gevensleben H, Cutts R, Snowdon C, Rea D, Cameron D, Shaaban A, Randle K, Martin S, Wilkinson K, Moretti L, Bliss JM, Ring A. Turner NC, et al. Among authors: moretti l. Lancet Oncol. 2020 Oct;21(10):1296-1308. doi: 10.1016/S1470-2045(20)30444-7. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919527 Free PMC article. Clinical Trial.
Genomic profile of advanced breast cancer in circulating tumour DNA.
Kingston B, Cutts RJ, Bye H, Beaney M, Walsh-Crestani G, Hrebien S, Swift C, Kilburn LS, Kernaghan S, Moretti L, Wilkinson K, Wardley AM, Macpherson IR, Baird RD, Roylance R, Reis-Filho JS, Hubank M, Faull I, Banks KC, Lanman RB, Garcia-Murillas I, Bliss JM, Ring A, Turner NC. Kingston B, et al. Among authors: moretti l. Nat Commun. 2021 Apr 23;12(1):2423. doi: 10.1038/s41467-021-22605-2. Nat Commun. 2021. PMID: 33893289 Free PMC article.
Discovery of NSD2-Degraders from Novel and Selective DEL Hits.
LegaardAndersson J, Christensen J, Kleine-Kohlbrecher D, Vacher Comet I, Fullerton Støier J, Antoku Y, Poljak V, Moretti L, Dolberg J, Jacso T, Jensby Nielsen S, Nørregaard-Madsen M, Franch T, Helin K, Cloos PAC. LegaardAndersson J, et al. Among authors: moretti l. Chembiochem. 2023 Dec 14;24(24):e202300515. doi: 10.1002/cbic.202300515. Epub 2023 Oct 24. Chembiochem. 2023. PMID: 37807669
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.
Kingston B, Pearson A, Herrera-Abreu MT, Sim LX, Cutts RJ, Shah H, Moretti L, Kilburn LS, Johnson H, Macpherson IR, Ring A, Bliss JM, Hou Y, Toy W, Katzenellenbogen JA, Chandarlapaty S, Turner NC. Kingston B, et al. Among authors: moretti l. Cancer Discov. 2024 Feb 8;14(2):274-289. doi: 10.1158/2159-8290.CD-22-1387. Cancer Discov. 2024. PMID: 37982575 Free PMC article.
436 results